EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control

Xingyu Long, Min Liu, Yayun Nan, Qiaohui Chen, Zuoxiu Xiao, Yuting Xiang, Xiaohong Ying, Jian Sun, Qiong Huang, Kelong Ai iD

Advanced Materials · 2024-05 · 36 (18)

DOI: 10.1002/adma.202308239 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 29.01.2024. Verfasst von Xingyu Long und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China. Hauptthemen laut MEDLINE: Mitochondria, Nanotechnology. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 391 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Science Fund for Distinguished Young Scholar of China, Innovation-Driven Project of Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria, widely known as the energy factories of eukaryotic cells, have a myriad of vital functions across diverse cellular processes. Dysfunctions within mitochondria serve as catalysts for various diseases, prompting widespread cellular demise. Mounting research on remedying damaged mitochondria indicates that mitochondria constitute a valuable target for therapeutic intervention against diseases. But the less clinical practice and lower recovery rate imply the limitation of traditional drugs, which need a further breakthrough. Nanotechnology has approached favorable regiospecific biodistribution and high efficacy by capitalizing on excellent nanomaterials and targeting drug delivery. Mitochondria‐remedying nanodrugs have achieved ideal therapeutic effects. This review elucidates the significance of mitochondria in various cells and organs, while also compiling mortality data for related diseases. Correspondingly, nanodrug‐mediate therapeutic strategies and applicable mitochondria‐remedying nanodrugs in disease are detailed, with a full understanding of the roles of mitochondria dysfunction and the advantages of nanodrugs. In addition, the future challenges and directions are widely discussed. In conclusion, this review provides comprehensive insights into the design and development of mitochondria‐remedying nanodrugs, aiming to help scientists who desire to extend their research fields and engage in this interdisciplinary subject.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaNanotechnologyAnimalsHumansDrug Delivery SystemsNanomedicineNanoparticlesNanostructures

Stichwörter der Autor:innen

mitochondriananodrugsoxidative stresstarget delivery

Autor:innen und Institutionen

  • Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410078, P. R. China.
  • Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, P. R. China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China.
  • Geriatric Medical Center, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, 750002, P. R. China.
  • College of Pharmacy, Xinjiang Medical University, Urumqi, 830017, P. R. China.

ORCID-Profile: Kelong Ai

Förderung

  • National Natural Science Foundation of China
  • Hunan Science Fund for Distinguished Young Scholar of China
  • Innovation-Driven Project of Central South University
  • Hunan Provincial Natural Science Foundation of China
  • Central South University Research Programme of Advanced Interdisciplinary Studies
  • Key Research Project of Ningxia Hui Autonomous Region of China (Major Project)
  • Key Program of Ningxia Hui Autonomous Region Natural Science Foundation of China

Zitieren

APA

Long, X., Liu, M., Nan, Y., Chen, Q., Xiao, Z., Xiang, Y., Ying, X., Sun, J., Huang, Q., & Ai, K. (2024). Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control. Advanced Materials, 36(18). https://doi.org/10.1002/adma.202308239

Vancouver

Long X, Liu M, Nan Y, Chen Q, Xiao Z, Xiang Y, et al. Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control. Advanced Materials. 2024;36(18). doi:10.1002/adma.202308239

BibTeX
@article{Long2024,
  author = {Long, Xingyu and Liu, Min and Nan, Yayun and Chen, Qiaohui and Xiao, Zuoxiu and Xiang, Yuting and Ying, Xiaohong and Sun, Jian and Huang, Qiong and Ai, Kelong},
  title = {Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {18},
  doi = {10.1002/adma.202308239}
}
Kostenlos starten →